Skip to main content
. 2000 Jul 18;97(16):8910–8915. doi: 10.1073/pnas.160255697

Figure 3.

Figure 3

MTM1 mutations associated with severe myotubular myopathy dramatically decrease the phosphatase activity of myotubularin. Recombinant wild-type or mutant (P205L, R241L, S376N, G378R, Y397C) myotubularin fusion proteins were tested for their ability to dephosphorylate pNPP and PI(3)P substrates. Phosphatase assays were conducted at 30°C as described in Materials and Methods. Values are expressed as percent wild-type myotubularin activity (mean ± SEM).